Concepedia

Capsule Dissolution Profiles

Capsule Dissolution Profiles is a quantitative metric that characterizes the rate and extent of active pharmaceutical ingredient release from a capsule dosage form under standardized in vitro conditions, distinguishing it from other capsule compatibility indicators by specifically capturing temporal dissolution behavior critical for bioavailability and formulation interchangeability assessments.

174

Publications

4.7K

Citations

703

Authors

221

Institutions

Publications per year

2017–2026

24

Variants

Capsule Dissolution Profile

Parents

Publications

174

Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and Capsules

John G. Wagner · Journal of Pharmaceutical Sciences · 1969 · 498 citations

, , +16

Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol

N. Rouge, Éric Allémann, Marianne Gex‐Fabry et al. · Pharmaceutica Acta Helvetiae · 1998 · 111 citations · Full text

, , +17

The Shell Dissolution of Various Empty Hard Capsules.

Irene Chiwele, Brian E. Jones, Fridrun Podczeck · Chemical and Pharmaceutical Bulletin · 2000 · 88 citations · Full text

, , +17

Evaluation and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules

L Kassaye, G Genete · African Health Sciences · 2013 · 80 citations · Full text

, , +17

Investigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation

Hitesh S. Purohit, Niraj S. Trasi, Dajun Sun et al. · Journal of Pharmaceutical Sciences · 2017 · 68 citations

, , +17

1–5 of 174

Authors

703

  1. LL
    Larry L. Augsburger

    University of Maryland, Baltimore, United States

    5 publications · 134 citations

    5

    h-index

  2. KG
    Kirsti Gjellan

    AstraZeneca (Sweden), Sweden

    4 publications · 50 citations

    4

    h-index

  3. MA
    Mansoor A. Khan

    Center for Drug Evaluation and Research, United States

    4 publications · 72 citations

    4

    h-index

  4. SD
    Sathish Dharani

    Texas A&M Health Science Center, United States

    3 publications · 57 citations

    3

    h-index

  5. BE
    Brian E. Jones

    Cardiff University, United Kingdom

    3 publications · 134 citations

    3

    h-index

1–5 of 703

Institutions

221

  1. United States Food and Drug Administration

    Silver Spring, United States

    6 h-index

    23 publications

    616 citations

  2. University of Maryland, Baltimore

    Baltimore, United States

    5 h-index

    14 publications

    368 citations

  3. Shenyang Pharmaceutical University

    Shenyang, China

    4 h-index

    24 publications

    421 citations

  4. Texas A&M University

    College Station, United States

    4 h-index

    21 publications

    417 citations

  5. Universidade Federal do Rio Grande do Sul

    Porto Alegre, Brazil

    4 h-index

    14 publications

    421 citations

  6. University of Nottingham

    Nottingham, United Kingdom

    3 h-index

    7 publications

    102 citations

  7. Bristol-Myers Squibb (United States)

    New York, United States

    3 h-index

    8 publications

    138 citations

  8. University of London

    London, United Kingdom

    3 h-index

    8 publications

    390 citations

1–8 of 221

Venues

  1. International Journal of Pharmaceutics

    21 publications · 524 citations

    15

    h-index

  2. Journal of Pharmaceutical Sciences

    18 publications · 914 citations

    14

    h-index

  3. Drug Development and Industrial Pharmacy

    21 publications · 357 citations

    13

    h-index

  4. Journal of Pharmacy and Pharmacology

    JPP · 12 publications · 287 citations

    11

    h-index

  5. PubMed

    Repository · 9 publications · 178 citations

    9

    h-index

1–5